Fabrice DENIS MD PhD
Fabrice DENIS MD PhD
Cancérologue, Centre Jean Bernard, Le Mans, France
Adresse e-mail validée de cjb72.org
Titre
Citée par
Citée par
Année
Final results of the 94–01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced …
F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ...
Journal of clinical oncology 22 (1), 69-76, 2004
8962004
Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT …
F Denis, P Garaud, E Bardet, M Alfonsi, C Sire, T Germain, P Bergerot, ...
International Journal of Radiation Oncology* Biology* Physics 55 (1), 93-98, 2003
2622003
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study
MC Garassino, BC Cho, JH Kim, J Mazières, J Vansteenkiste, H Lena, ...
The Lancet Oncology 19 (4), 521-536, 2018
2332018
Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients
F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ...
JNCI: Journal of the National Cancer Institute 109 (9), 2017
1782017
Two-year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer
F Denis, E Basch, AL Septans, J Bennouna, T Urban, AC Dueck, ...
Jama 321 (3), 306-307, 2019
1162019
Sensitization by dietary docosahexaenoic acid of rat mammary carcinoma to anthracycline: a role for tumor vascularization
S Colas, K Mahéo, F Denis, C Goupille, C Hoinard, P Champeroux, ...
Clinical cancer research 12 (19), 5879-5886, 2006
1032006
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer
F Denis, AV Desbiez-Bourcier, C Chapiron, F Arbion, G Body, ...
European Journal of Surgical Oncology (EJSO) 30 (10), 1069-1076, 2004
1032004
Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid
S Colas, L Paon, F Denis, M Prat, P Louisot, C Hoinard, O Le Floch, ...
International journal of cancer 109 (3), 449-454, 2004
882004
What can be learned from a chaotic cancer model?
C Letellier, F Denis, LA Aguirre
Journal of theoretical biology 322, 7-16, 2013
802013
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial
X Pivot, G Romieu, M Debled, JY Pierga, P Kerbrat, T Bachelot, ...
The Lancet 393 (10191), 2591-2598, 2019
552019
Improving survival in patients treated for a lung cancer using self-evaluated symptoms reported through a web application
F Denis, S Yossi, AL Septans, A Charron, E Voog, O Dupuis, G Ganem, ...
American journal of clinical oncology 40 (5), 464-469, 2017
482017
In vivo quantitation of tumour vascularisation assessed by Doppler sonography in rat mammary tumours
F Denis, P Bougnoux, L de Poncheville, M Prat, R Catroux, F Tranquart
Ultrasound in medicine & biology 28 (4), 431-437, 2002
472002
Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 study)
P Vera, S Thureau, P Chaumet-Riffaud, R Modzelewski, P Bohn, ...
Journal of Nuclear Medicine 58 (7), 1045-1053, 2017
462017
Detection of lung cancer relapse using self-reported symptoms transmitted via an internet web-application: pilot study of the sentinel follow-up
F Denis, L Viger, A Charron, E Voog, O Dupuis, Y Pointreau, C Letellier
Supportive Care in Cancer 22 (6), 1467-1473, 2014
412014
Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequences
S Dewas, JE Bibault, P Blanchard, C Vautravers-Dewas, Y Pointreau, ...
Radiation Oncology 6 (1), 118, 2011
372011
How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment?
D Ghosh, S Khajanchi, S Mangiarotti, F Denis, SK Dana, C Letellier
BioSystems 158, 17-30, 2017
362017
Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): a phase II trial
R Gervais, G Robinet, C Clément-Duchêne, F Denis, C El Kouri, P Martin, ...
Lung Cancer 80 (2), 185-190, 2013
352013
Overall survival in patients with lung cancer using a web-application-guided follow-up compared to standard modalities: Results of phase III randomized trial.
F Denis, C Lethrosne, N Pourel, O Molinier, Y Pointreau, J Domont, ...
Journal of Clinical Oncology 34 (18_suppl), LBA9006-LBA9006, 2016
342016
Early assessment of metabolic response by 18F-FDG PET during concomitant radiochemotherapy of non–small cell lung carcinoma is associated with survival: a retrospective single …
S Yossi, S Krhili, JP Muratet, AL Septans, L Campion, F Denis
Clinical nuclear medicine 40 (4), e215-e221, 2015
292015
Early variation of FDG-PET radiomics features in NSCLC is related to overall survival-the “delta radiomics” concept
S Carvalho, RTH Leijenaar, EGC Troost, W van Elmpt, JP Muratet, ...
Radiotherapy and Oncology 118, S20-S21, 2016
282016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20